RARE
Ultragenyx Pharmaceutical Inc. · Healthcare
Chief Financial Officer Howard Horn sold $117K of Ultragenyx Pharmaceutical Inc.
Sold$117,024
$24.92Price
4,696Shares
−5%Stake
What RARE did after the filing
- The stock from Tue, Aug 4 close, $25.81
- −43.8%
- S&P 500, same days
- −1.1%
Measured over 30 trading days, to the Sep 17 close.
Traded Mon, Aug 3. Filed Tue, Aug 4, 3:13 PM ET, during the session. Returns use the Aug 4 close and the Sep 17 close. Not investment advice.